Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazone. Front Endocrinol (Lausanne). 2024 Aug 30:15:1420485. YR Li, CC Wang, CH Liu, CL Yen, Victor CC Wu, Evelyn JC Huang, CY Lee, CC Hsiao.
